Should We Accept Colistin-Induced Nephrotoxicity To Ensure Attainment of a Therapeutic Steady State in Those with Good Renal Function?
- PMID: 29802204
- PMCID: PMC5971583
- DOI: 10.1128/AAC.00351-18
Should We Accept Colistin-Induced Nephrotoxicity To Ensure Attainment of a Therapeutic Steady State in Those with Good Renal Function?
Keywords: clinical therapeutics; pharmacodynamics; pharmacokinetics; polymyxins; renal failure; tetracyclines.
Comment on
-
A Retrospective Cohort Analysis Shows that Coadministration of Minocycline with Colistin in Critically Ill Patients Is Associated with Reduced Frequency of Acute Renal Failure.Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01165-17. doi: 10.1128/AAC.01165-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29038261 Free PMC article.
References
-
- Lodise TP, Fan W, Griffith DC, Dudley MN, Sulham KA. 2018. A retrospective cohort analysis shows that coadministration of minocycline with colistin in critically ill patients is associated with reduced frequency of acute renal failure. Antimicrob Agents Chemother 62:e01165-17. doi: 10.1128/AAC.01165-17. - DOI - PMC - PubMed
-
- Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP, Forrest A, Nation RL. 2011. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agent Chemother 55:3284–3294. doi: 10.1128/AAC.01733-10. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
